What does IGF-1 LR3 do?
Quick answer: IGF-1 LR3 (Insulin-Like Growth Factor 1 Long R3) is a synthetic analog of IGF-1 with an extended half-life (reported at 20-30 hours) and reduced binding to IGF binding proteins. It binds IGF-1 receptors and activates growth-promoting signaling such as PI3K-AKT-mTOR, which is why it is widely used in cell-culture and preclinical studies of cell proliferation, differentiation and muscle-cell signaling. It is sold for laboratory research use only.
What is IGF-1 LR3?
IGF-1 LR3 (Insulin-Like Growth Factor 1 Long R3) is a synthetic analog of IGF-1, a naturally occurring peptide hormone involved in growth, development and cell regeneration. The “LR3” modification gives it an extended half-life and reduced binding to IGF binding proteins compared with native IGF-1, which is why it is widely used in cell-culture and laboratory research.
Research Findings on IGF-1 LR3:
Muscle Cell Studies:
- Stimulates muscle cell proliferation and differentiation in cell-culture models.
- Studied in models of muscle repair after experimental injury.
- Examined for effects on protein synthesis and protein breakdown in laboratory systems.
Metabolic Research:
- Studied for effects on lipid metabolism in experimental models.
- Used in research on insulin signaling and nutrient partitioning.
Cellular Energy Research:
- Investigated for effects on ATP production and cellular energy metabolism.
Tissue Repair Models:
- Studied in preclinical models of tendon, ligament and other tissue repair.
- Examined for effects on inflammatory signaling.
Cellular Regeneration Research:
- Studied for its role in cell growth in skin, bone and organ tissue models.
- Investigated in neuroprotection and nerve growth research.
Nutrient Uptake:
- Studied for its role in amino acid and glucose transport into muscle cells.
How IGF-1 LR3 Works:
IGF-1 LR3 binds to IGF-1 receptors found in muscle and other tissues, activating anabolic (growth-promoting) signaling pathways such as PI3K-AKT-mTOR. Its extended half-life (reported at 20-30 hours) gives it a longer duration of activity than native IGF-1 in research settings.
Safety Observations in the Literature:
Because of its insulin-like and proliferative activity, researchers note the following considerations:
- Hypoglycemia: Its insulin-like activity can lower blood glucose in experimental models.
- Cell proliferation: Its growth-promoting activity is a key consideration in study design.
For laboratory research, Transparent Peptides lists IGF-1 LR3 1mg (one vial, 1mg lyophilized powder). Research use only.
IGF-1 LR3 Structure and Research Use
- IGF-1 LR3 is a modified IGF-1 analog (Arg3 substitution plus an N-terminal extension) with reduced binding to IGF binding proteins, giving it an extended half-life in research settings.
- It is widely used in cell-culture and preclinical studies of cell proliferation, differentiation and muscle-cell signaling.
- For laboratory research it is supplied as a 1mg vial of lyophilized powder.
FAQ
What is IGF-1 LR3?
IGF-1 LR3 (Insulin-Like Growth Factor 1 Long R3) is a synthetic analog of IGF-1. Its modification (an Arg3 substitution plus an N-terminal extension) gives it reduced binding to IGF binding proteins and an extended half-life in research settings.
How does IGF-1 LR3 work in research models?
IGF-1 LR3 binds to IGF-1 receptors and activates growth-promoting signaling pathways such as PI3K-AKT-mTOR. Its half-life is reported at 20-30 hours, longer than native IGF-1.
What safety considerations are noted in the IGF-1 LR3 literature?
Researchers note that its insulin-like activity can lower blood glucose in experimental models, and that its growth-promoting activity on cell proliferation is a key consideration in study design.
How is IGF-1 LR3 supplied?
Transparent Peptides lists IGF-1 LR3 1mg (one vial, 1mg lyophilized powder) for laboratory research use only.
All products referenced are sold strictly for laboratory research use only and are not for human or veterinary consumption.


